Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02143063 · ClinicalTrials.gov registry record · NA
Extending Long-term Outcomes Through an Adaptive Aftercare Intervention
A NA study, sponsored by UConn Health.
- Completed
- Registry status
- NA
- Development phase
- 274
- Enrollment target
NCT02143063 is a NA study that has completed, run by UConn Health. The registered enrollment target is 274 participants.
The verdict
NCT02143063, a NA study, has completed, sponsored by UConn Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 274 participants
- Enrollment target
Study Summary
Reinforcement interventions have pronounced effects on reducing cocaine use. This study will evaluate a novel approach in which reinforcement frequency varies by patient performance. To test efficacy, 280 patients with cocaine use disorder will be randomly assigned to: standard care, standard care plus traditional twice weekly reinforcement, or standard care plus adaptive variable interval reinforcement.
Interventions
- BEHAVIORAL standard care
- BEHAVIORAL prize contingency management on a traditional twice weekly schedule for cocaine abstinence
- BEHAVIORAL prize contingency management on a variable interval schedule for cocaine abstinence
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 274 participants |
| Start Date | 2014-08 |
| Est. Completion | 2020-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02143063
The ClinicalTrials.gov registry entry for NCT02143063 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 274 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is UConn Health, which has 178 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which standard care is the first listed.
NCT02143063 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02143063 about?
NCT02143063 is a clinical study titled "Extending Long-term Outcomes Through an Adaptive Aftercare Intervention". Reinforcement interventions have pronounced effects on reducing cocaine use. This study will evaluate a novel approach in which reinforcement frequency varies by patient performance. To test efficacy, 280 patients with cocaine use disorder will be randomly assigned to: standard care, standard care p...
What is the current status of trial NCT02143063?
This trial is currently completed. It is a NA study. The enrollment target is 274 participants. The study started on 2014-08. Estimated completion is 2020-10.
What interventions are being tested in trial NCT02143063?
The interventions under investigation include: standard care (BEHAVIORAL), prize contingency management on a traditional twice weekly schedule for cocaine abstinence (BEHAVIORAL), prize contingency management on a variable interval schedule for cocaine abstinence (BEHAVIORAL).
Who is sponsoring clinical trial NCT02143063?
This trial is sponsored by UConn Health, which has 178 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.